ClinicalTrials.Veeva

Menu

New Method to Close Nasal Septal Perforation

H

Helwan University

Status

Enrolling

Conditions

Nasal Perforated Septum

Treatments

Device: Polycaprolactone nasal mesh

Study type

Interventional

Funder types

Other

Identifiers

NCT06439927
self sponsored

Details and patient eligibility

About

The goal of this clinical trial is to investigate if a 3-dimensional fabricated nasal mesh works to close nasal septal perforations. Under general anesthesia, during nasal septal perforation repair surgery, the investigator will place the mesh between the elevated mucoperichondrial flaps opposite the site of the perforation and confirm its original position at both sides under nasal endoscope. Endoscopic examination for septal mucosa status will be done monthly for a three months follow up period.

Enrollment

23 estimated patients

Sex

All

Ages

18 to 58 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing nasal septal perforation repair surgery.

Exclusion criteria

  • Patients with known allergy to polycaprolactone.
  • Pregnancy or lactation.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

23 participants in 1 patient group

Polycaprolactone nasal mesh
Experimental group
Treatment:
Device: Polycaprolactone nasal mesh

Trial contacts and locations

1

Loading...

Central trial contact

Mohamed H Sebaey, Master degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems